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The GABAA receptor modulators propofol and diazepam are in clinical use as anesthetics, 
anxiolytics and anticonvulsants. However, both drugs, particularly at high doses, cause 
clinically undesired effects. Propofol can cause irregular heart rate and low blood 
pressure, while diazepam, like many other benzodiazepines, has long-lasting effects. 
Thus, it can be clinically advantageous to find ways to administer lower doses of these 
drugs while still maintaining overall efficacy. One approach is to combine either drug 
with another GABAergic agent, such as a potentiating neuroactive steroid that by itself 
has minimal effect. In this study, we looked at the ability of the steroid alfaxalone to 
amplify GABAergic responses to either propofol or diazepam using three experimental 
approaches. In the first experiment, we used whole-cell patch clamp to study the effect 
of combinations of alfaxalone with either propofol or diazepam on decay times of 
spontaneous inhibitory postsynaptic currents (sIPSCs) in rat hippocampal neurons. Co-
application of 300 nM, but not 10 nM, alfaxalone with propofol or diazepam resulted 
in an enhancement of the decay time constant of sIPSCs. Next, we verified these results 
on recombinant human a1β2γ2L GABAA receptors expressed in Xenopus oocytes using 
two-electrode voltage clamp. We found that exposure to alfaxalone enhanced the ability 
of propofol or diazepam to potentiate responses to a low concentration of GABA. In 
the third experiment, we studied the effect of alfaxalone on loss-of-righting induced 
by propofol or diazepam in Xenopus tadpoles. Loss of righting is a proxy for loss of 
consciousness and mediated by actions on GABAA receptors. We observed left-shifted 
dose-response curves during coapplication of alfaxalone with propofol or diazepam. 
These results demonstrate that coapplication of alfaxalone can result in reduced dosage 
requirement for propofol and diazepam.
